The average Medicare Advantage monthly premium in 2021 will be $21, a 11% decrease from 2020 premiums.
WASHINGTON – CMS announced yesterday its estimated 2021 monthly Medicare Advantage (MA) premiums. According to the agency, the average MA monthly premium in 2021 will be $21, a 11% decrease from 2020 premiums and a 34% reduction from 2017 premiums. In addition, CMS announced that the average number of plan choices per county will increase from 39 plans in 2020 to 47 plans in 2021. Overall, nearly 5000 MA plans will be available across the country in 2021.
CMS also announced that MA enrollment is projected to reach approximately 26.9 million enrollees next year, up from 24.4 million enrollees in 2020. That means that MA will cover 42% of all Medicare beneficiaries.
“America’s seniors are increasingly choosing Medicare Advantage because it delivers better services, better access to care, and better value,” said Matt Eyles, president and CEO of America’s Health Insurance Plans. “And polls show that people in Medicare Advantage are overwhelmingly satisfied with their plan. That’s why we’ll continue to fight for a strong and stable program—both now and in the future.”
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More
2 Commerce Drive
Cranbury, NJ 08512